Break'n News - World and US News, Headlines, business, politics and more
44.74 F
New York
April 3, 2020
Home » Johnson & Johnson

Johnson & Johnson

CNBC Business

Wall Street extends last week’s gains

CNBC
CNBC – For more and to sign up click here Dow Jones Industrial Average jumps 690 points The Dow gained 690.70 points, or 3.19% to close at 22,327.48. The S&P 500 climbed 3.35% to 2,626,65. The Nasdaq Composite advanced 3.62% to 7,774.15. Stocks rallied on Monday as the U.S. extended......
CNBC Business

Johnson & Johnson to begin clinical trials on coronavirus vaccine by Sept

CNBC
CNBC – For more and to sign up click here Johnson & Johnson stock climbed 8% Monday after the company said human testing of its experimental vaccine for the coronavirus will begin by September and it could be available for emergency use authorization in early 2021. J&J also said it has......
CNBC Business

Cramer warns shorts about betting against science in coronavirus

CNBC
CNBC – For more and to sign up click here Jim Cramer Scott Mlyn | CNBC CNBC’s Jim Cramer argued Monday that stock market short sellers are unwisely doubting the ability of scientists to slow the spread of the new coronavirus. “This is a day where you say, if I’m short I’m......
CNBC Business

5 things to know before the stock market opens March 30, 2020

CNBC
CNBC – For more and to sign up click here 1. Futures turn positive after Dow’s best week in 82 years U.S. stock futures turned positive and were pointing to a gain for the Dow Jones Industrial Average at Monday’s open after President Donald Trump extended national social-distancing guidelines to April......
CNBC Business

J&J hopes to start human trials for coronavirus vaccine in November

CNBC
CNBC – For more and to sign up click here Johnson & Johnson hopes to begin human clinical trials on a COVID-19 vaccine in early November, its chief scientific officer, Dr. Paul Stoffels, told CNBC on Tuesday.  “We are making significant progress and very, very fast,” Stoffels said on “The......
CNBC Business

Trump is enlisting Big Pharma to stem the coronavirus crisis

CNBC
CNBC – For more and to sign up click here As confirmed cases of the coronavirus continue to rise, President Donald Trump has quickly embraced the pharmaceutical industry he once vilified for its high prices. The industry has, in turn, jumped on the opportunity.  COVID-19 has killed at least 19......

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Click whichever is suitable. Accept Read More